Atlas Trials

Relapsed/Refractory Hodgkin's Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed/Refractory Hodgkin's Lymphoma

RecordFirmDate
BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in R/R HL Patients Non Responding to IGEV (NCT02244021)Fondazione Italiana Linfomi - ETS2014-12-01

Track Relapsed/Refractory Hodgkin's Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.